CYPH CYPHERPUNK TECHNOLOGIES INC. — earnings, filings & institutional moves

Price chart

Daily historical data with per-account defaults

Latest close

$0.62

Period return

-0.20 (-24.61%)

Volume

806.1K

2026-07-24O $0.67 H $0.67 L $0.62 C $0.62MA5 $0.68MA20 $0.68MA60 $0.86MA120 $0.8

6M · 125 barsYahoo Finance · USD2026-01-26 → 2026-07-24

Recent event timeline

Filings, earnings, research, and institutional changes — newest first

View all →

2026. 08. 13.Highin 18 days
다음 실적 발표 예정
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
2026. 05. 15.High2 months ago
13F 기관 보유 변화 — TWO SIGMA INVESTMENTS, LP
신규 편입 · 포트폴리오 비중 0.00%
2021. 09. 30.Medium5 years ago
2022년 3분기 실적 발표
실적이 발표되었습니다. 세부 수치와 가이던스는 원문에서 확인하세요.
2021. 06. 30.Medium5 years ago
2022년 2분기 실적 발표
실적이 발표되었습니다. 세부 수치와 가이던스는 원문에서 확인하세요.
2021. 03. 31.Medium5 years ago
2022년 1분기 실적 발표
실적이 발표되었습니다. 세부 수치와 가이던스는 원문에서 확인하세요.
2020. 09. 30.Medium6 years ago
2020년 3분기 실적 발표
실적이 발표되었습니다. 세부 수치와 가이던스는 원문에서 확인하세요.
2020. 09. 30.Medium6 years ago
2021년 3분기 실적 발표
실적이 발표되었습니다. 세부 수치와 가이던스는 원문에서 확인하세요.
2020. 06. 30.Medium6 years ago
2020년 2분기 실적 발표
실적이 발표되었습니다. 세부 수치와 가이던스는 원문에서 확인하세요.
2020. 06. 30.Medium6 years ago
2021년 2분기 실적 발표
실적이 발표되었습니다. 세부 수치와 가이던스는 원문에서 확인하세요.
2020. 03. 31.Medium6 years ago
2020년 1분기 실적 발표
실적이 발표되었습니다. 세부 수치와 가이던스는 원문에서 확인하세요.

Recent earnings

Consensus vs. actual, and revenue trend

Earnings tab →

Research actions

Rating & price-target changes

Research tab →

AI Brief (Premium)

Automated summary from public sources · not investment advice

Brief tab →

No AI brief generated yet. You can create one from the Brief tab.

Top institutions (13F)

Ranked by position value

Institutions tab →

Company info

Cypherpunk Technologies Inc., a privacy technology company, implements a digital asset strategy anchored by Zcash in the United States. The company is involved in identifying, developing, investing in, acquiring, and building privacy-enhancing technologies; and accumulating digital assets, such as ZCash. It also develops biomarker-targeted antibody therapies for patients with cancer and other diseases comprising DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which has completed Phase 2 study for the treatment of colorectal cancer; and FL-501, a monoclonal antibody inhibiting the GDF-15 protein, which is in preclinical development to treat cancer cachexia, hyperemesis gravidarum and pregnancy-related nausea and vomiting, and other diseases associated with aging and frailty. The company was formerly known as Leap Therapeutics, Inc. and changed its name to Cypherpunk Technologies Inc. in November 2025. Cypherpunk Technologies Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.

Sector: Financial Services
Industry: Asset Management
HQ: Cambridge, MA, United States
Fiscal year end: —
Employees: 6
IPO date

Quarter	Date	Time	EPS est.	EPS actual	Surprise	Rev. est.	Rev. actual	Status
—	2026. 08. 13.	After market close (AMC)	—	—	—	—	—	Scheduled
FY2022 Q3	2021. 09. 30.	Time TBD	—	$-0.39	—	—	$1.13M	Reported
FY2022 Q2	2021. 06. 30.	Time TBD	—	$-0.24	—	—	$750K	Reported
FY2022 Q1	2021. 03. 31.	Time TBD	—	$-0.12	—	—	$375K	Reported

#	Institution	Mandate	Shares	Value	Weight	Change	Position
1	TWO SIGMA INVESTMENTS, LP	TWO SIGMA INVESTMENTS, LP	72,172	$83.72K	0.00%	—	New position
2	TWO SIGMA INVESTMENTS, LP	TWO SIGMA INVESTMENTS, LP	66,572	$52.9K	0.00%	—	New position

CYPHERPUNK TECHNOLOGIES INC.

Price chart

Recent event timeline

Recent earnings

Research actions

Top news

Key stats